Intellia Therapeutics Inc. (NTLA)
Market Closed
17 Jul, 20:00
$
11. 38
-0.48
-4.0894%
$
1.6B Market Cap
- P/E Ratio
- Div Yield
4.33M Volume
-5.42 Eps
$ 11.86
Previous Close 
Want to track NTLA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Intellia Therapeutics Inc. (NTLA) Statistics
Valuation metrics
Market Cap 1.6B
Enterprise value 1.22B
Trailing P/E (ttm) -3.21
Forward P/E -4.75
PEG ratio -0.08
Price/Sales (ttm) 19.31
Price/Book (mrq) 2.17
Enterprise Value/Revenue 18.49
Enterprise Value/EBITDA -3.18
Overview
Shares outstanding 116.32M
Float 111.94M
Shares short 38.81M
% Held by insiders 0.05%
% Held by institutions 0.86%
Average volume (10 days) 4.32M
Average volume (90 days) 8.19M
Price summary
52-Week low 7.95
52-Week high 28.25
Beta 1.99
50-Day moving average 14.06
200-Day moving average 13.11
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -5.97%
Operating margin -6.37%
Operational effectiveness
Return on assets -0.52%
Return on equity -0.57%
Income Statement
Revenue (ttm) 67.67M
Revenue per share (ttm) 0.56
Quarterly revenue growth (yoy) 0.79%
Gross profit (ttm) -256.78M
EBITDA -431.22M
Net income to common (ttm) -412.69M
Diluted EPS (ttm) -3.33
Quarterly earnings growth (yoy) 0.79%
Balance Sheet
Total cash (mrq) 449.88M
Total cash per share (mrq) 3.17
Total debt (mrq) 93.33M
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 6.1%
Book value per share (mrq) 5.24
Cash Flow
Cash flow statement -394.74M
Levered free cash flow (LFCF) -233.29M
